Related Experiment Video
Updated: Dec 20, 2025
10:24
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
Published on: May 15, 2018
15.2K
Neuromodulation of Epilepsy Networks
Nathaniel D Sisterson1, Vasileios Kokkinos2
1Department of Neurological Surgery, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
Neurosurgery Clinics of North America
|June 2, 2020
Summary
Neuromodulation therapy for drug-refractory epilepsy is improving, especially with closed-loop devices. This approach customizes treatment based on individual neurophysiology, offering a promising, minimally invasive option for broader epilepsy types.
Area of Science:
- Neurology
- Biomedical Engineering
Background:
- Neuromodulation offers therapeutic potential for drug-refractory epilepsy.
- Current understanding of neuromodulation's precise mechanisms remains limited.
- Open-loop and closed-loop devices represent distinct generations of neuromodulation technology.
Purpose of the Study:
- To explore the therapeutic efficacy of neuromodulation in epilepsy management.
- To highlight the significance of personalized neurophysiology in device programming.
- To assess the potential of closed-loop stimulation for expanded epilepsy indications.
Main Methods:
- Review of recent evidence on neuromodulation for epilepsy.
- Analysis of device programming parameters in relation to patient neurophysiology.
- Evaluation of therapeutic outcomes based on neuromodulation strategies.
Main Results:
- Therapeutic efficacy can be achieved by modulating seizure networks, not just disrupting seizure evolution.
- Closed-loop stimulation demonstrates a minimally invasive and nondestructive approach.
- Personalized programming based on neurophysiology is key to treatment precision.
Conclusions:
- Closed-loop neuromodulation shows promise for treating drug-refractory epilepsy.
- The minimally invasive nature of closed-loop systems suggests potential for generalized and pediatric epilepsy.
- Further research is needed to fully elucidate the mechanisms and optimize outcomes of neuromodulation therapies.
More Related Videos
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
716
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
716
01:24Epilepsy and Seizures: Overview
1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
01:14Antiepileptic Drugs: Glutamate Antagonists
791
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
791
01:20Antiepileptic Drugs: Potassium Channel Activators
524
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
524
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K